During pregnancy, see Antimalarial treatment in pregnant women. Pre-referral treatment If the patient needs to be transferred, administer before transfer: At community level, for children under 6 years: one dose of rectal artesunate d (10 mg/kg) Children 2 months to < 3 years (≤ 10 kg): 1 rectal capsule (100 mg) Children 3 to < 6 years (≤ 20 kg): 2 rectal capsules (200 mg) or At dispensary level, for children and adults: the first dose of artesunate or, if unavailable, the first dose of artemether. For dosing information, see below. In either case, provide patients, especially children, with some sugar prior to or during transfer. Inpatient treatment The drug of choice is artesunate, preferably IV, or if not possible IM. For patients in shock: IM route is not appropriate, use artesunate IV only. artesunate slow IV injection (3 to 5 minutes) or, if not possible, slow IM injection, into the anterior thigh: Children under 20 kg: 3 mg/kg/dose Children 20 kg and over and adults: 2.4 mg/kg/dose One dose on admission (H0) One dose 12 hours after admission (H12) One dose 24 hours after admission (H24) Then one dose once daily Treat parenterally for at least 24 hours (3 doses), then, if the patient can tolerate the oral route, change to a complete 3-day course of an ACT. If not, continue parenteral treatment once daily until the patient can change to oral route (without exceeding 7 days of parenteral treatment). If artesunate is not unavailable, artemether may be an alternative: artemether IM into the anterior thigh (never administer by IV route) Children and adults: 3.2 mg/kg on admission (D1) then 1.6 mg/kg once daily Treat parenterally for at least 24 hours (2 doses), then, if the patient can tolerate the oral route, change to a complete 3-day course of